PRA conducted a survey at the 2018 Alzheimer's Association International Conference in Chicago. Across the board we found that the research community remains optimistic for a cure or disease modifying treatment for Alzheimer’s, with particular faith in the amyloid hypothesis. Industry, advocacy groups, academia, and many other stakeholders in clinical development continue to embrace new technologies and data science with the hope that one day these will contribute toward bringing treatments to the right patients at the right stage of the disease.

Explore related content and topics